Cargando…
Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs)
Glucocorticoids (GCs) are commonly used to treat autoimmune and inflammatory diseases, but their clinical effects and long-term use can lead to serious side effects. New drugs that can replace GCs are needed. Glucocorticoid-induced leucine zipper (GILZ) is induced by GCs and mediates many of their a...
Autores principales: | Paglialunga, Musetta, Flamini, Sara, Contini, Raffaele, Febo, Marta, Ricci, Erika, Ronchetti, Simona, Bereshchenko, Oxana, Migliorati, Graziella, Riccardi, Carlo, Bruscoli, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528232/ https://www.ncbi.nlm.nih.gov/pubmed/37759516 http://dx.doi.org/10.3390/cells12182294 |
Ejemplares similares
-
Glucocorticoid-Induced Leucine Zipper: A Novel Anti-inflammatory Molecule
por: Bereshchenko, Oxana, et al.
Publicado: (2019) -
Role of histamine H(4) receptor in the anti-inflammatory pathway of glucocorticoid-induced leucin zipper (GILZ) in a model of lung fibrosis
por: Sgambellone, Silvia, et al.
Publicado: (2023) -
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
por: Cappetta, Donato, et al.
Publicado: (2021) -
Glucocorticoid-Induced Leucine Zipper Inhibits Interferon-Gamma Production in B Cells and Suppresses Colitis in Mice
por: Bruscoli, Stefano, et al.
Publicado: (2018) -
Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment
por: Flamini, Sara, et al.
Publicado: (2021)